| CAS No. | 933720-55-9 |
| Molecular Formula | C10H20N2O |
| Molecular Weight | 184.28 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including 2-(Pyrrolidin-1-ylmethyl)-1,4-oxazepane.
CATO supplies 2-(Pyrrolidin-1-ylmethyl)-1,4-oxazepane (CAS 933720-55-9), a certified reference material (molecular formula C10H20N2O, MW 184.28 g/mol) for analytical method development and quality control.
The molecular framework of 2-(Pyrrolidin-1-ylmethyl)-1,4-oxazepane (C10H20N2O) is characterized by an amide group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by its high hydrophobicity (logP), which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The high carbon-to-hydrogen ratio imparts good lipophilicity, allowing liquid-liquid extraction with non-polar solvents such as n-hexane or ethyl acetate.
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
CATO manufactures 2-(Pyrrolidin-1-ylmethyl)-1,4-oxazepane under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
| Molecular Formula | C10H20N2O |
| Molecular Weight | 184.28 g/mol |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 2.0 |
| CAS Registry Year (est.) | 1987 |
| Nitrogen Atoms | 2 |